Literature DB >> 18408929

Autoimmune retinopathy: a review and summary.

John R Heckenlively1, Henry A Ferreyra.   

Abstract

Three main forms of autoimmune retinopathy (AIR) have been identified over the last 15 years: cancer-associated retinopathy (CAR), melanoma-associated retinopathy (MAR), and nonneoplastic autoimmune retinopathy (npAIR). In this chapter, the term AIR will be used to encompass all three disorders where there is commonality to their features. Complicating the issue is that AIR can be a secondary complication of other conditions such as retinitis pigmentosa, ocular trauma, birdshot retinopathy, acute zonal occult outer retinopathy (AZOOR), or multiple evanescent white dot syndrome (MEWDS). The many forms of AIR tend to have common clinical features despite the fact that there has been no uniform set of anti-retinal antibodies circulating in these patients. Patients tend to have a wide variance of anti-retinal antibody activity often with three to six different antibodies found on immunoblots. Patients typically present with a sudden onset of photopsia, rapid visual loss, and abnormal electroretinograms (ERGs). Most patients have a panretinal degeneration without pigment deposits.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408929     DOI: 10.1007/s00281-008-0114-7

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  27 in total

Review 1.  Retinopathies associated with antiretinal antibodies.

Authors:  J J Hooks; M O Tso; B Detrick
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.

Authors:  C E Thirkill; P FitzGerald; R C Sergott; A M Roth; N K Tyler; J L Keltner
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

3.  The incidence of negative ERG in clinical practice.

Authors:  A H Koh; C R Hogg; G E Holder
Journal:  Doc Ophthalmol       Date:  2001-01       Impact factor: 2.379

Review 4.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

5.  Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa.

Authors:  J R Heckenlively; B L Jordan; N Aptsiauri
Journal:  Am J Ophthalmol       Date:  1999-05       Impact factor: 5.258

Review 6.  Melanoma-associated retinopathy: does autoimmunity prolong survival?

Authors:  C Chan; J O'Day
Journal:  Clin Exp Ophthalmol       Date:  2001-08       Impact factor: 4.207

7.  Severe course of cutaneous melanoma associated paraneoplastic retinopathy.

Authors:  U Kellner; N Bornfeld; M H Foerster
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

8.  The cancer-associated retinopathy antigen is a recoverin-like protein.

Authors:  C E Thirkill; R C Tait; N K Tyler; A M Roth; J L Keltner
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-09       Impact factor: 4.799

Review 9.  Paraneoplastic retinopathies and optic neuropathies.

Authors:  Jane W Chan
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

10.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.

Authors:  A H Milam; J C Saari; S G Jacobson; W P Lubinski; L G Feun; K R Alexander
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

View more
  79 in total

1.  Slowly progressive non-neoplastic autoimmune-like retinopathy.

Authors:  Kouichi Ohta; Takanobu Kikuchi; Noriko Yoshida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-13       Impact factor: 3.117

2.  Cystoid macular changes on optical coherence tomography in a patient with maternally inherited diabetes and deafness (MIDD)-associated macular dystrophy.

Authors:  Cynthia X Qian; Kari Branham; Naheed Khan; Steven K Lundy; John R Heckenlively; Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2017-01-31       Impact factor: 1.803

3.  Autologous antibodies to outer retina in acute zonal occult outer retinopathy.

Authors:  Mizuki Tagami; Wataru Matsumiya; Hisanori Imai; Sentaro Kusuhara; Shigeru Honda; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2014-10-01       Impact factor: 2.447

Review 4.  The enigma of autoimmune retinopathy.

Authors:  Farzin Forooghian; Sijia Cao; Jing Cui; Joanne A Matsubara
Journal:  Int Ophthalmol Clin       Date:  2015

5.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.

Authors:  D Pisa; R Alonso; F J Jiménez-Jiménez; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-16       Impact factor: 3.267

6.  Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.

Authors:  Ying Lu; Lin Jia; Shirley He; Mary C Hurley; Monique J Leys; Thiran Jayasundera; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2009-12

7.  Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology.

Authors:  Peter A Calabresi; Laura J Balcer; Elliot M Frohman
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

8.  Paraneoplastic retinopathy associated with retroperitoneal liposarcoma.

Authors:  Mineo Kondo; Kumiko Mokuno; Ai Uemura; Shu Kachi; Makoto Nakamura; Atsuya Kondo; Hiroko Terasaki
Journal:  Clin Ophthalmol       Date:  2010-04-26

9.  Two mouse models for recoverin-associated autoimmune retinopathy.

Authors:  Ying Lu; Shirley He; Lin Jia; Naheed W Khan; John R Heckenlively
Journal:  Mol Vis       Date:  2010-10-02       Impact factor: 2.367

10.  Autoimmune retinopathy in systemic lupus erythematosus: histopathologic features.

Authors:  Xiaoguang Cao; Rachel J Bishop; Farzin Forooghian; Youngeun Cho; Robert N Fariss; Chi-Chao Chan
Journal:  Open Ophthalmol J       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.